Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
5,402
Views
25
CrossRef citations to date
0
Altmetric
Coronaviruses

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination

Meiyu Wanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of China;b Graduate School of Peking Union Medical College, Beijing, People’s Republic of ChinaView further author information
,
Li Zhanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
,
Qianqian Lic Jiangsu Recbio Technology Co., Ltd., Taizhou, People’s Republic of ChinaView further author information
,
Bo Wangd Beijing Advanced Innovation Center for Genomics (ICG) & Biomedical Pioneering Innovation Center (BIOPIC), Peking University; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People’s Republic of China.View further author information
,
Ziteng Lianga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of China;b Graduate School of Peking Union Medical College, Beijing, People’s Republic of ChinaView further author information
,
Yeqing Suna Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
,
Jianhui Niea Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
,
Jiajing Wua Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaView further author information
,
Xiaodong Sud Beijing Advanced Innovation Center for Genomics (ICG) & Biomedical Pioneering Innovation Center (BIOPIC), Peking University; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People’s Republic of China.View further author information
,
Xiaowang Que Translational Medicine Institute, The First People’s Hospital of Chenzhou, University of South China, Chenzhou, People’s Republic of ChinaView further author information
,
Yuhua Lif Department of Arboviral Vaccine, National Institutes for Food and Drug Control, Beijing, People’s Republic of ChinaView further author information
,
Youchun Wanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of China;b Graduate School of Peking Union Medical College, Beijing, People’s Republic of ChinaView further author information
&
Weijin Huanga Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 18-29 | Received 26 Sep 2021, Accepted 15 Nov 2021, Published online: 21 Dec 2021

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Li Zhang, Qianqian Li, Ziteng Liang, Tao Li, Shuo Liu, Qianqian Cui, Jianhui Nie, Qian Wu, Xiaowang Qu, Weijin Huang & Youchun Wang. (2022) The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerging Microbes & Infections 11:1, pages 1-5.
Read now

Articles from other publishers (24)

Farina Karim, Catherine Riou, Mallory Bernstein, Zesuliwe Jule, Gila Lustig, Strauss van Graan, Roanne S. Keeton, Janine-Lee Upton, Yashica Ganga, Khadija Khan, Kajal Reedoy, Matilda Mazibuko, Katya Govender, Kershnee Thambu, Nokuthula Ngcobo, Elizabeth Venter, Zanele Makhado, Willem Hanekom, Anne von Gottberg, Monjurul Hoque, Quarraisha Abdool Karim, Salim S. Abdool Karim, Nithendra Manickchund, Nombulelo Magula, Bernadett I. Gosnell, Richard J. Lessells, Penny L. Moore, Wendy A. Burgers, Tulio de Oliveira, Mahomed-Yunus S. Moosa & Alex Sigal. (2024) Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation. Nature Communications 15:1.
Crossref
Craig A. Magaret, Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson, James Ludwig, Cindy Molitor, David Benkeser, Alex Luedtke, Brian Simpkins, Fei Heng, Yanqing Sun, Lindsay N. Carpp, Hongjun Bai, Bethany L. Dearlove, Elena E. Giorgi, Mandy Jongeneelen, Boerries Brandenburg, Matthew McCallum, John E. Bowen, David Veesler, Jerald Sadoff, Glenda E. Gray, Sanne Roels, An Vandebosch, Daniel J. Stieh, Mathieu Le Gars, Johan Vingerhoets, Beatriz Grinsztejn, Paul A. Goepfert, Leonardo Paiva de Sousa, Mayara Secco Torres Silva, Martin Casapia, Marcelo H. Losso, Susan J. Little, Aditya Gaur, Linda-Gail Bekker, Nigel Garrett, Carla Truyers, Ilse Van Dromme, Edith Swann, Mary A. Marovich, Dean Follmann, Kathleen M. Neuzil, Lawrence Corey, Alexander L. Greninger, Pavitra Roychoudhury, Ollivier Hyrien & Peter B. Gilbert. (2024) Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nature Communications 15:1.
Crossref
Junli Jia, Emanuela Garbarino, Yuhang Wang, Jiaming Li, Minmin Song, Xin Zhang, Xinjie Wang, Lingyun Li, Jing Chi, Lunbiao Cui & Huamin Tang. (2024) Generation of SARS‐CoV‐2 spike receptor binding domain mutants and functional screening for immune evaders using a novel lentivirus‐based system. Journal of Medical Virology 96:1.
Crossref
Yunbo Tu & Xinzhu Meng. (2023) A reaction–diffusion epidemic model with virus mutation and media coverage: Theoretical analysis and numerical simulation. Mathematics and Computers in Simulation 214, pages 28-67.
Crossref
I. S. Vladimirov, A. S. Zhdanova, V. E. Mukhin, V. V. Makarov, V. S. Yudin & S. A. Kraevoy. (2023) Identification and functional characteristic of SARS-CoV-2-specific T lymphocytes in COVID-19 patients up to 16 months after disease onset. Medical Immunology (Russia) 26:3, pages 555-568.
Crossref
Shannon Harger Payen, Andrew Gorzalski, Danielle Denise Siao, Mark Pandori, Subhash C. Verma & Cyprian C. Rossetto. (2023) Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021. Infection, Genetics and Evolution 111, pages 105434.
Crossref
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, Nirav Shah, Sachin Verma, Shrinivas Savale & Suma Ray. (2023) Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update. Process Biochemistry 127, pages 66-81.
Crossref
Tiantian Han, Ziqing Luo, Lichun Ji, Peng Wu, Geng Li, Xiaohong Liu & Yanni Lai. (2023) Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation. Frontiers in Microbiology 13.
Crossref
Bo Wang, Hua Xu, Zi-teng Liang, Tian-ning Zhao, Xin Zhang, Tian-bo Peng, You-chun Wang & Xiao-dong Su. (2023) Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2. International Journal of Biological Macromolecules 227, pages 896-902.
Crossref
Charlotte M. Miton & Nobuhiko Tokuriki. (2022) Insertions and Deletions (Indels): A Missing Piece of the Protein Engineering Jigsaw. Biochemistry 62:2, pages 148-157.
Crossref
Toong Seng Tan, Mako Toyoda, Hirotaka Ode, Godfrey Barabona, Hiroshi Hamana, Mizuki Kitamatsu, Hiroyuki Kishi, Chihiro Motozono, Yasumasa Iwatani & Takamasa Ueno. (2022) Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike. Journal of Virology 96:20.
Crossref
Xiaohui Hu, Cheng Lin, Qin Xu, Xuelan Zhou, Pei Zeng, Peter J. McCormick, Haihai Jiang, Jian Li & Jin Zhang. (2022) Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor. Viruses 14:9, pages 2075.
Crossref
Zhikai Zhang, Xuan Wan, Xinyue Li, Shaoxi Cai & Chengsong Wan. (2022) Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2. Viruses 14:9, pages 2020.
Crossref
Liqing Chen, Xiaoxiao Qi, Dan Liang, Guiqi Li, Xiaofang Peng, Xiaohui Li, Bixia Ke, Huanying Zheng, Zhongqiu Liu, Changwen Ke, Guochao Liao, Liang Liu & Qian Feng. (2022) Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants. Vaccines 10:9, pages 1502.
Crossref
Jian Li, Cheng Lin, Xuelan Zhou, Fanglin Zhong, Pei Zeng, Peter J. McCormick, Haihai Jiang & Jin Zhang. (2022) Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814. Journal of Molecular Biology 434:16, pages 167706.
Crossref
Cong Sun, Chu Xie, Guo-Long Bu, Lan-Yi Zhong & Mu-Sheng Zeng. (2022) Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Signal Transduction and Targeted Therapy 7:1.
Crossref
Wenqiang Sun, Lihong He, Huicong Lou, Wenhui Fan, Limin Yang, Gong Cheng, Wenjun Liu & Lei Sun. (2022) The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs. Frontiers in Immunology 13.
Crossref
Lorenzo Subissi, Anne von Gottberg, Lipi Thukral, Nathalie Worp, Bas B. Oude Munnink, Surabhi Rathore, Laith J. Abu-Raddad, Ximena Aguilera, Erik Alm, Brett N. Archer, Homa Attar Cohen, Amal Barakat, Wendy S. Barclay, Jinal N. Bhiman, Leon Caly, Meera Chand, Mark Chen, Ann Cullinane, Tulio de Oliveira, Christian Drosten, Julian Druce, Paul Effler, Ihab El Masry, Adama Faye, Simani Gaseitsiwe, Elodie Ghedin, Rebecca Grant, Bart L. Haagmans, Belinda L. Herring, Shilpa S. Iyer, Zyleen Kassamali, Manish Kakkar, Rebecca J. Kondor, Juliana A. Leite, Yee-Sin Leo, Gabriel M. Leung, Marco Marklewitz, Sikhulile Moyo, Jairo Mendez-Rico, Nada M. Melhem, Vincent Munster, Karen Nahapetyan, Djin-Ye Oh, Boris I. Pavlin, Thomas P. Peacock, Malik Peiris, Zhibin Peng, Leo L. M. Poon, Andrew Rambaut, Jilian Sacks, Yinzhong Shen, Marilda M. Siqueira, Sofonias K. Tessema, Erik M. Volz, Volker Thiel, Sylvie van der Werf, Sylvie Briand, Mark D. Perkins, Maria D. Van Kerkhove, Marion P. G. Koopmans & Anurag Agrawal. (2022) An early warning system for emerging SARS-CoV-2 variants. Nature Medicine 28:6, pages 1110-1115.
Crossref
Shengyuan DangLili RenJianwei Wang. (2022) Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape. Chinese Medical Journal 135:10, pages 1213-1222.
Crossref
Raluca Dumache, Alexandra Enache, Ioana Macasoi, Cristina Adriana Dehelean, Victor Dumitrascu, Alexandra Mihailescu, Roxana Popescu, Daliborca Vlad, Cristian Sebastian Vlad & Camelia Muresan. (2022) SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern. Pathogens 11:5, pages 516.
Crossref
Yaw-Syan Fu, Wan-Yi Ho, Ning Kang, May-Jywan Tsai, Jingyi Wu, Liyue Huang & Ching-Feng Weng. (2022) Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Frontiers in Pharmacology 13.
Crossref
Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, Fabio Paredes, Claudia P. Cortes, Sergio Pantano, Constanza Martínez-Valdebenito, Jenniffer Angulo, Nicole Le Corre, Marcela Ferrés, Marcelo A. Navarrete, Fernando Valiente-Echeverría & Ricardo Soto-Rifo. (2022) Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile. Nature Microbiology 7:4, pages 524-529.
Crossref
Michael Zhipeng Yan, Ming Yang & Ching-Lung Lai. (2022) Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It. Frontiers in Drug Discovery 2.
Crossref
Cong Sun, Yin-Feng Kang, Yuan-Tao Liu, Xiang-Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yi-Hao Liu, Sui Peng, Guo-Kai Feng, Zheng Liu & Mu-Sheng Zeng. (2022) Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants. Signal Transduction and Targeted Therapy 7:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.